Hepatitis B and C in the patients with chronic renal failure undergoing dialysis treatment;Wirusowe zapalenie wa̧troby (WZW) typu B i C u chorych z przewlekŁa̧ niewydolnościa̧ nerek leczonych dializami

Polskie Archiwum Medycyny Wewnetrznej

Volumn 96, Issue 5, 1996, Pages 484-489

  Niemczyk, Stanisław ^a  

^a Staeji Dializ Szpitala ^*  (Poland)

Author keywords

CAPD; Chronic renal failure; Haemodialysis; Hepatitis B; Hepatitis C; Therapy; Vaccination

Indexed keywords

HEPATITIS VACCINE;

CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; RENAL REPLACEMENT THERAPY; REVIEW;

HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; VIRAL HEPATITIS VACCINES;

EID: 2842603507     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Szmunes W., Prince A.M., Grady G.F. i wsp.: Hepatitis B infection: A point prevelance study in 15 US hemodialysis centers. JAMA, 1974, 227, 901.
2. Snydman D.R., Bregman D., Bryan J.A.: Hemodialysis-associated hepatitis in the United States. J. Infect. Dis., 1977, 135, 687.
3. Aller M.J., Favero M.S., Mover L.A., Bland L A.: National surveillance of dialysis-associated diseases in the Unites States. ASSAIO Trans., 1989, 37, 97.
4. Degas F., Lugassy C., Degott C. i wsp.: Succesfull vaccination with intradermal hepatitis by vaccine in hemodialysis patients previously nonresponsive to intramuscular hepatitis B vaccine. J. Am. Soc. Nephrol., 1995, 5, 1930.
5. Sieniuta P., Chouraqui D.: Hepatitis B intradermal vaccination in dialysis patients - long term survey. Abstracts Eur. Dial. Transpl. Assoc., Amsterdam, 1996, 293.
6. Martin P., Friedman L.S.: Chronic viral hepatitis and the management of chronic renal failure. Kidney Inter., 1995, 47, 1231.
7. Kochler H.: Hepatitis B immunization in dialysis patients - is it worthwhile? Nephrol. Dial. Transplant, 1994, 9, 1719.
8. Oesterreicher C., Hammer J., Koch U. i wsp.: HBV and HCV genome in periferal blood momonuclear cells in patients undergoing chronic hemodialysis. Kidney Intern , 1995, 48, 1967.
9. Crosnier J., Jungers P., Courouce A.M. i wsp.: Randomized placebo-controlled trial of hepatitis S surface antigen in French hemodialysis units. Medical staff. Lancet, 1981, 1, 455.
10. Zuckerman A.J.: Present and future hepatitis β vaccines, w Oxford Textbool of Clinical Hepatology wyd. Mc Intyre i wsp. J. Oxford, University Press, 1991, 620.
11. Jungers P., Devillier P., Salomon H., Cerisier J.E., Courouce A.M.: Randomized placebo-controlled trial of recombinant interleukin-2 in chronic viremic patients who are non-responders to hepatitis B vaccine. Lancet, 1994, 344, 856.
12. Kohler H., Arold W., Renschin G., Dormeyer H.M., Burchenfelde M.Z.. Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Intern., 1984, 25, 124.
13. Bruguera M., Rodicio J.L., Alcazar J.M., Olivier A., Del Rio G., Estaban-Mur R.. Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in hemodialysis patients. Am. J. Nephrol., 1990, 8, 547.
14. buti M., Viladomine L., Jardi R. i wsp.: Long term immunogenicity and efficacy of hepatitis B vaccine in hemidialysis patients. Am. J. Nephrol., 1992, 12, 144.
15. Carvalho B.M., Guerra N.J , diogo B., Baldaja J., Fernandes J.C., Leao M.B.: Hepatitis B immunization in patients with end-stage renal failure: what is important timing or route? Abstracts Eur. Dial. Transpl Assoc. Amsterdam 1996, 254.
16. Meuer S.C., Dumann H., Meuer K.H., Kohler H . Low-dose Interleukin-2 induces systemic immune responses against HBs Ag in immunodeficient non-responders to hepatitis B vaccination. Lancet, 1989, 1, 15.
17. Jibani M.M , Heptonstall J., Walker A.M., Bloodworth L.O , Howard A.J.: Hepatitis B immunization in UK renal units: failure to put policy into practice. Nephrol. Dial. Transplant., 1994, 9, 1765.
18. Cendoroglo Neto M., Dratbe S.A. i wsp.: Incidence of and risk factor for hepatitis B virus and hepatitis C virus infection among hemodialysis and CAPD patients: evidence for anvirronmental transmission. Nephrol. Dial. Transplant., 1995, 10, 240.
19. Stallone C., Anccella F., Di Tulio M , Vigillante M.. Prevention of hepatitis infection in teh dialysis setting: comparison of different strategies. Abstracts Eur. Dial. Transpl. Assoc., Amsterdam, 1996, 251.
20. Gerlich W., Thomssen R.: Terminology, structure and laboratory diagnosis of hepatitis viruses w: Mc Intyre N. i wsp., wyd. Textbool of Clinical Hepatology. Oxfort University Press, New York, 1991, 562-563.
21. Mc Farlane I., Smith H., Jonson P., Bray G., Vergani D., Williams R.̧ Hepatitis C virus antibody in chronic active hepatitis: pathogenetic factor or false positive results? Lancet, 1990, 335, 562.
22. Gretch D., Lee W , Corey L.̧ Use of aminotransferase. hepatitis C antibody and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory, J. Clin. Microbiol., 1992, 30, 2145.
23. courouce A.M., Bouchardeau F , Chaveau P. i wsp.: Hepatitis C virus (HCV) infection in hemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays). Nephron. Dial. Transplant., 1995, 10, 234.
24. Bouchardeau F., Chauveau P., le Marrec N., Girault A., Zins B., Courouce A.M.: Detection of hepatitis C virus by polymerase chain reaction in hemodialyzed patients in relationship to anti-HCV status. Res. Virol., 1993, 144, 223.
25. Chan T.M., Lok A.S.F., Cheng I.K.P., Chan R.T.: Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study companing the results of RNA and antibody assys. Hepatology, 1993, 17, 5.
26. Giammoria U , De Meo F., Acitelli S. i wsp.: HCV infection in hemodialysis patients. Incidence and correlation with dialytic age. Nephron, 1992, 61, 335.
27. Davis G.L., Balart L.A., Schiff E.R. Treatment of chronic hepatitis C with interferon alfa. N. Engl. J. Med., 1989, 321, 1501.
28. Druwe P.M., Michielsen P.P., Ramon A.M., De Broe M.E.: Hepatitis C and nephrology. Nephrol. Dial. Transplant., 1994, 9, 230.
29. Pereira P., Milford E., Kirkman R.. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N. Engl. J. Med., 1992, 327, 910.
30. Desenclos J.C., Drucker J.: Transmission du virus de L hepatide C.: Certitudes et hypotheses. Presse Med., 1995, 24, 7.
31. Cahour A.. Les perspectives dun vaccin contre 1 hepatide C. quelle strategic adopter. Medicine, 1995, 11, 81.
32. di Bisceglie A.M., Martin P., Kassianides C.: Recombinant Interferon alpha therapy for chronic hepatitis C. N. Engl. J. Med., 1989, 321, 1506.
33. Malaguarnera M., Restuccia S., Trovato G , Siciliano R., Motta M., Trovato B.A.: Interferon alfa treatment in patients with chronic hepatitis. Clin. Drug Invest., 1995, 9, 141.
34. Pawlotsky J.M., Dhumeauux D.: Le traitment de l hepatite chronique C. Presse Med., 1995, 24, 141.
35. Poynard T., Bedossa P., Chevallier M. i wsp.: A comparision of three interferon alpha-2b regiment for the long-term treatment of chronic non-A, non-B hepatitis. N. Engl. J.Med., 1995, 332, 1457.
36. Piazza F., Segagni S., Pogio F., Efficace E., Galli F., Picardi L.: HCV prevelance in haemodialysis patients. Results of a six year surveillance. Abstracts Eur. Dial. Transpl Assoc. Amsterdam 1996, 248.
37. Ariinsay T., Bali M., sindel S., Yilmaz M., Hasangloi E.: Prevelance of hepatitis E virus antibody in heamodialysis patients. Abstracts Eur. Dial. Transpl Assoc., Amsterdam, 1996, 232.